Clorox Reports Q2 Results Amid Challenges and Acquisition
Clorox Co's stock rose by 3.04% as it reached a 20-day high, despite the broader market decline with the Nasdaq-100 down 0.71% and the S&P 500 down 0.02%.
The company reported Q2 fiscal 2026 results showing a 1% decline in net sales year-over-year, attributed to inventory drawdowns and market share losses. However, Clorox announced the acquisition of GOJO Industries, aiming to enhance its leadership in health and hygiene, which could strengthen its competitive position. Additionally, the company plans to invest $60 million in digital capabilities to improve operational efficiency.
Despite the challenges, Clorox's strategic moves, including the acquisition and digital investments, indicate a focus on long-term growth, which may help the company navigate current market pressures.
Trade with 70% Backtested Accuracy
Analyst Views on CLX
About CLX
About the author

- Investor Sentiment Shift: Following earnings calls from tech giants like Microsoft, Google, and Amazon, investor confusion about future directions led to Amazon losing over $300 billion in market cap, reflecting strong skepticism regarding its $200 billion AI investment plan.
- Capital Expenditure Comparison: Google announced an increase in capital expenditures to $175 billion to $185 billion, exceeding the expected $115 billion to $120 billion, indicating a proactive approach in AI despite challenges from slowing ad revenues.
- Changing Competitive Landscape: With Alphabet's ongoing investments and successes in AI, YouTube's user base has grown to 750 million, and Waymo's self-driving business is outpacing Tesla, suggesting a strengthening competitive advantage that may attract more investor interest.
- Mixed Market Reactions: Despite OpenAI and Anthropic's strong performance in AI, Microsoft's Copilot sales have been disappointing, highlighting investor concerns about its future growth and reflecting differing levels of confidence across companies.
- REIT Investment: Realty Income (O), a leading real estate investment trust, owns over 15,000 commercial properties primarily leased to consumer-facing businesses, offering a 5.3% dividend yield that ensures steady cash flow for investors amid economic fluctuations.
- Food Industry Leader: General Mills (GIS) boasts annual sales exceeding $18 billion; despite challenges from consumers shifting to generic brands, its long dividend history and current valuation at just 12 times earnings make it an attractive buy with a consistent payout.
- Cleaning Products Leader: Clorox (CLX) is renowned for its bleach and cleaning products, recently acquiring Purell for $2.25 billion, and as a Dividend King with 50 consecutive years of dividend increases, it offers a 4.4% yield, appealing to income-focused investors.
- Market Environment Analysis: While the broader market remains near highs, increased volatility in tech stocks serves as a reminder for investors to diversify their portfolios, with steady consumer goods stocks providing effective risk mitigation, especially in the face of rising economic uncertainty.
- Executive Attendance: Clorox's Chair and CEO Linda Rendle, along with CFO Luc Bellet, will speak at the CAGNY annual conference in Orlando, Florida, on February 19, 2026, showcasing the company's leadership in consumer analysis.
- Live Webcast Details: The presentation will be broadcast live at 2:00 PM ET (11:00 AM PT), allowing for broad audience participation and brand exposure through access on Clorox's official website.
- Replay Availability: Following the event, a replay of the webcast will be made available, further enhancing information dissemination and interaction with investors and consumers.
- Company Background: Founded in 1913, Clorox integrates sustainability into its operations and boasts a portfolio of trusted brands, including Brita, Burt's Bees, and Clorox, emphasizing its significance in consumers' daily lives.
- Portfolio Adjustment: In the second half of 2025, I increased my investment in Brookfield Renewable Partners due to its diversification in renewable energy, including hydro, solar, wind, and nuclear power, which is expected to drive future revenue growth.
- Attractive Yield: Brookfield Renewable Partners currently offers a high yield of 5%, and its partnerships with Microsoft and Google further enhance its market competitiveness, attracting more investor interest.
- Market Dynamics Response: Due to tightening consumer spending, I sold Hormel Foods and Clorox at the end of 2025 to offset gains elsewhere, but I reinvested in both stocks in early 2026, reflecting confidence in their long-term growth potential.
- Growth Potential: Hormel Foods and Clorox offer yields of 4.7% and 4.5%, respectively, and both companies have a history of dividend growth, with expectations that new leadership and the acquisition of Gojo will help them return to growth trajectories.
- Renewable Energy Investment: In the second half of 2025, I increased my investment in Brookfield Renewable Partners due to its presence in hydroelectric, solar, wind, and nuclear energy sectors, with partnerships with Microsoft and Google providing strong growth potential.
- Dividend Appeal: Brookfield Renewable offers a 5% dividend yield, making it an attractive option for investors, especially as global demand for renewable energy continues to rise, likely enhancing its market position.
- Consumer Goods Market Dynamics: With a shift towards healthier eating impacting the consumer staples sector negatively, I sold Hormel Foods and Clorox in late 2025 to realize losses, but I increased my positions in both stocks in early 2026, reflecting confidence in their growth potential.
- Growth Potential: Hormel Foods' new CEO and restructuring efforts are expected to drive a return to growth, while Clorox's planned acquisition of Gojo, a leading hand sanitizer company, is anticipated to strengthen its market competitiveness and enhance shareholder returns.
- Earnings Highlights: Clorox reported an adjusted EPS of $1.39 for Q2, missing the analyst consensus of $1.43, although sales reached $1.673 billion, exceeding expectations of $1.64 billion, indicating resilience in revenue generation.
- Sales Decline: Net sales fell 1% year-over-year, primarily due to reduced consumption, despite a 2% increase in the Health and Wellness segment, demonstrating ongoing demand in that area.
- Margin Pressure: Gross margin decreased by 60 basis points to 43.2% year-over-year, driven by rising manufacturing and logistics costs, reflecting challenges in cost management for the company.
- Outlook Reaffirmed: Clorox reaffirmed its fiscal 2026 adjusted EPS guidance at $5.95 to $6.30, although a temporary inventory issue is expected to reduce sales growth by 7.5 percentage points, showcasing the company's ability to navigate uncertainties in the market.











